General Biologicals Corp. (GBC), founded in 1984, is the industry-leading in-vitro diagnostic device manufacturer in Taiwan. GBC is certified with IVD Class III, GMP and ISO 13485:2003. GBC has offices in Taipei.
Showing 1–12 of 61 results
For qualitative detection of antibodies to SARS-CoV-2 virus (anti-SARS-CoV-2) in human serum or plasma
An Enzyme Immunoassay (ELISA) kit for in vitro Semi-Quantitative the detection of IgG abd IgM antibodies to SARS-CoV-2 in human serum/plasma
For in-vitro qualitative detection of Hepatitis D virus infection in human serum or plasma
For in-vitro qualitative detection of Hepatitis D virus infection in human serum or plasma
For in-vitro qualitative detection and screening assay of HIV infection in human serum or plasma.
For in vitro qualitative detection and screening assay of Hepatitis C virus infection in human serum or plasma.
BioFibroScore® Kit is a non-invasive diagnostic tests for liver fibrosis
An Enzyme Immunoassay Kit For Antibody To HIV Type 1&2
For qualitative detection of antibodies to hepatitis A virus (Anti-HAV) in human serum or plasma.
For qualitative in-vitro detection of IgM antibodies to hepatitis A (Anti-HAV IgM) in human serum or plasma.
GB HBsAg ELISA Kit (SURASE B-96) Detecting Hepatitis B Surface Antigen
For in vitro qualitative detection of Antibody to Hepatitis B surface antigen(Anti-HBs) in human serum or plasma. The test can be used prior and after hepatitis B vaccination to assess the immune status as well as an aid to diagnose and monitor infections by hepatitis B virus.
For in-vitro qualitative detection of total antibody to hepatitis B virus core antigen (Anti-HBc total) in human serum or plasma.